Bertin Pharma, a pharmaceutical R&D contract service supplier and bioreagent supplier, has acquired a 1500m2 facility for the formulation and production of clinical batches of over-the-counter (OTC) drugs from Johnson & Johnson Santé Beauté France (JJSBF). The company will also provide R&D services to JJSBF.
With the JJSBF Martillac site acquisition, a workforce of 80 employees and 3500m2 of pharmaceutical GMP-compliant facilities, Bertin Pharma covers the whole drug development value chain, offering solutions in full packages or stand-alone versions.
Bertin Pharma, Hall 1, Stand H23